At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CSBR Champions Oncology
Post-Market Trading 09-19 17:40:52 EDT
4.89
+0.61
+14.25%
盘后4.88
-0.01-0.20%
16:58 EDT
High4.89
Low4.41
Vol76.25K
Open4.41
D1 Closing4.28
Amplitude11.22%
Mkt Cap66.47M
Tradable Cap23.92M
Total Shares13.59M
T/O356.95K
T/O Rate1.56%
Tradable Shares4.89M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Champions Oncology upgraded to buy by Craig-Hallum
Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, a dynamic analytic and visualization software that empowers cancer biologists to harness the power of computational science in a convenient and sophisticated tool. The company markets its products through internet, word of mouth, and sales force to patients and physicians. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.